platoseedplatoseed
We're building the first continuous hormone monitor.
$800K D2C revenue, $18M B2B contracts signed in <8 weeks. Clair is the first continuous hormone monitor- a jewelry-inspired wrist wearable that helps women understand their bodies and optimize their health. Clair leverages a custom biosensor stack and an in-house female biology world model to track estrogen, progesterone, LH, and PdG. Its unique hormonal insights can be applied to understanding skin health, fertility, mood changes, (peri)menopause, and female athletic optimization.
Clair Health is building the world’s first noninvasive continuous hormone monitor wearable for women, tracking estrogen, progesterone, LH, FSH, and PdG in real time. The device combines multimodal sensing and ML to decode hormonal patterns and provide ongoing hormonal insights alongside wellness metrics.
A wrist-worn wearable with a multi-modal sensor array that captures over 130 biomarkers related to cardiovascular, thermoregulatory, autonomic, electrodermal and other physiological signals. Uses machine learning models trained against clinical-grade hormone measurements to translate sensor data into continuous hormone estimates (estrogen, progesterone, LH, FSH, PdG) and related cycle phase insights, plus sleep, recovery, activity, HR, and HRV metrics. The product aims to replace separate calendars, home hormone tests, and fitness wearables by providing a single device and app where cycle is the primary signal.
Who it’s for: Women seeking real-time, continuous hormonal insights and cycle tracking across various life stages (including irregular cycles, fertility planning, perimenopause to menopause).
Founding Members program with limited spots, early access and pricing, ongoing clinical validation and trial planning, media coverage and partnerships.
AI primary care doctor
Perimenopause Care Platform
